PAR 13.0% 52.0¢ paradigm biopharmaceuticals limited..

Osteoarthritis medicine, page-27

  1. 200 Posts.
    lightbulb Created with Sketch. 1
    I would treat all of the above "media outlets" as paid fake news.

    Seriously. They have picked up a media release from somewhere.

    Don't you people have bullshit antennae ?

    That aside Pentosan Polysulfate has shown significant reduction in OA in animals and probably Veterinarians for the last 25 years.

    It will in my opinion end up having a clinical application in human medicine. Just it may not have the exclusive IP that your all wishing and hoping for and that is where the money is.

    If this is just a generic copy of a compound that gets TGA and other clearances then great for us old rugby players and skiers but probably not a windfall for investors.
    Last edited by wintervet: 11/10/17
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
52.0¢
Change
0.060(13.0%)
Mkt cap ! $82.30M
Open High Low Value Volume
47.0¢ 56.0¢ 40.0¢ $4.475M 8.971M

Buyers (Bids)

No. Vol. Price($)
1 12150 49.0¢
 

Sellers (Offers)

Price($) Vol. No.
52.0¢ 39994 1
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.